MNT-001

N/A

Report date: 2024/12/17 16:33:22

Base Information

Drug NameMNT-001
Drug Alias NameMNT-001
ClassificationBiologics > Protein drugs
Mechanisms of ActionInterleukin-15 receptors replacement
TargetsInterleukin-15 receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMinotaur Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMinotaur Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A